CRISPR Therapeutics
The latest news about CRISPR Therapeutics: headlines, AI summaries and the full story from every source.
- Cathie Wood Increases Stake in CRISPR Therapeutics Amid Strategic Developments
- CRISPR Therapeutics Stock Rises After Six-Session Losing Streak
- Cathie Wood Invests $362 Million in CRISPR Therapeutics Amid Promising R&D Developments
- Bank of America Maintains Buy Rating for Beam Therapeutics
- CRISPR Therapeutics Stock Experiences Volatility Amid Commercialization Challenges